Neuroimaging technologies are instrumental in tracking the progression of movement disorders. This track will cover the role of various imaging modalities in early diagnosis, disease progression, and treatment efficacy. From structural changes seen on MRI to the functional markers identified through PET and SPECT, participants will gain a comprehensive understanding of how neuroimaging supports personalized treatment plans.
Track 4-1: Structural Imaging in movement disorders
Track 4-2: Functional Imaging for Disease Progression
Track 4-3: Neuroimaging Biomarkers in Parkinson’s
Track 4-4: Imaging in Huntington’s Disease
Track 4-5: MRI and PET in Treatment Planning
Discover how neuroimaging helps clinicians tailor treatment approaches based on individualized brain imaging, opening new pathways for precision medicine in movement disorders.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
